Articles

Novel pyrrolobenzodiazepine benzofused hybrid molecules inhibit NF-κB activity and synergise with bortezomib and ibrutinib in hematological cancers

Division of Cancer & Genetics, Cardiff University School of Medicine, Heath Park, Cardiff, UK;
School of Cancer and Pharmaceutical Science, King College London, UK;
School of Cancer and Pharmaceutical Science, King College London, UK;
Cardiff University School of Medicine, Heath Park, Cardiff, UK;
Cardiff University School of Medicine, Heath Park, Cardiff, UK;
Division of Cancer & Genetics, Cardiff University School of Medicine, Heath Park, Cardiff, UK;
Division of Cancer & Genetics, Cardiff University School of Medicine, Heath Park, Cardiff, UK;
Brighton and Sussex Medical School, University of Sussex, Brighton, UK
School of Cancer and Pharmaceutical Science, King College London, UK;
Brighton and Sussex Medical School, University of Sussex, Brighton, UK
Haematologica Early view May 7, 2020 https://doi.org/10.3324/haematol.2019.238584